National Health Investors Statistics Share Statistics National Health Investors has 47.47M
shares outstanding. The number of shares has increased by 1.83%
in one year.
Shares Outstanding 47.47M Shares Change (YoY) 1.83% Shares Change (QoQ) 2.2% Owned by Institutions (%) 67.97% Shares Floating 45.21M Failed to Deliver (FTD) Shares 2,662 FTD / Avg. Volume 0.95%
Short Selling Information The latest short interest is 1.98M, so 4.32% of the outstanding
shares have been sold short.
Short Interest 1.98M Short % of Shares Out 4.32% Short % of Float 5.95% Short Ratio (days to cover) 7.39
Valuation Ratios The PE ratio is 22.02 and the forward
PE ratio is 22.76.
National Health Investors's PEG ratio is
68.92.
PE Ratio 22.02 Forward PE 22.76 PS Ratio 9.07 Forward PS 11.9 PB Ratio 2.22 P/FCF Ratio 14.92 PEG Ratio 68.92
Financial Ratio History Enterprise Valuation National Health Investors has an Enterprise Value (EV) of 4.16B.
EV / Sales 12.41 EV / EBITDA 15.75 EV / EBIT 20.02 EV / FCF 20.42
Financial Position The company has a current ratio of 0.96,
with a Debt / Equity ratio of 0.84.
Current Ratio 0.96 Quick Ratio 0.96 Debt / Equity 0.84 Debt / EBITDA 4.34 Debt / FCF 5.63 Interest Coverage 0
Financial Efficiency Return on Equity is 10.1% and Return on Invested Capital is 7.26%.
Return on Equity 10.1% Return on Assets 5.28% Return on Invested Capital 7.26% Revenue Per Employee $11.17M Profits Per Employee $4.6M Employee Count 30 Asset Turnover 0.13 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 1.9% in the
last 52 weeks. The beta is 0.76, so National Health Investors's
price volatility has been higher than the market average.
Beta 0.76 52-Week Price Change 1.9% 50-Day Moving Average 71.31 200-Day Moving Average 72.6 Relative Strength Index (RSI) 65.96 Average Volume (20 Days) 280,140
Income Statement In the last 12 months, National Health Investors had revenue of 335.18M
and earned 137.99M
in profits. Earnings per share was 3.14.
Revenue 335.18M Gross Profit 324.02M Operating Income 183.86M Net Income 137.99M EBITDA 264.16M EBIT 192.71M Earnings Per Share (EPS) 3.14
Full Income Statement Balance Sheet The company has 24.29M in cash and 1.15B in
debt, giving a net cash position of -1.12B.
Cash & Cash Equivalents 24.29M Total Debt 1.15B Net Cash -1.12B Retained Earnings 2.6B Total Assets 2.7B Working Capital 103.68M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 207.77M
and capital expenditures -4.07M, giving a free cash flow of 203.7M.
Operating Cash Flow 207.77M Capital Expenditures -4.07M Free Cash Flow 203.7M FCF Per Share 4.65
Full Cash Flow Statement Margins Gross margin is 96.67%, with operating and profit margins of 54.85% and 41.17%.
Gross Margin 96.67% Operating Margin 54.85% Pretax Margin 40.75% Profit Margin 41.17% EBITDA Margin 78.81% EBIT Margin 54.85% FCF Margin 60.77%
